Journal articles on the topic 'Pyocyanin, Staphylococcus aureus peptidoglycan'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Pyocyanin, Staphylococcus aureus peptidoglycan.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Vemula, Harika, Navid J. Ayon, and William G. Gutheil. "Cytoplasmic peptidoglycan intermediate levels in Staphylococcus aureus." Biochimie 121 (February 2016): 72–78. http://dx.doi.org/10.1016/j.biochi.2015.11.017.
Szweda, Piotr, Marta Schielmann, Roman Kotlowski, Grzegorz Gorczyca, Magdalena Zalewska, and Slawomir Milewski. "Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus." Applied Microbiology and Biotechnology 96, no. 5 (October 18, 2012): 1157–74. http://dx.doi.org/10.1007/s00253-012-4484-3.
Pozur, V. V., L. M. Skivka, and G. P. Potebnia. "Peptidoglycan Staphylococcus aureus and its immune-biological features." Biopolymers and Cell 24, no. 1 (January 20, 2008): 3–13. http://dx.doi.org/10.7124/bc.00078a.
GROV, A., and K. SVEEN. "INDUCTION OF LEUKOCHEMOTAXIS BY PEPTIDOGLYCAN OF STAPHYLOCOCCUS AUREUS." Acta Pathologica Microbiologica Scandinavica Section B Microbiology 86B, no. 1-6 (August 15, 2009): 375–78. http://dx.doi.org/10.1111/j.1699-0463.1978.tb00059.x.
Fournier, Bénédicte, and Dana J. Philpott. "Recognition of Staphylococcus aureus by the Innate Immune System." Clinical Microbiology Reviews 18, no. 3 (July 2005): 521–40. http://dx.doi.org/10.1128/cmr.18.3.521-540.2005.
Mattsson, Eva, Heiko Herwald, Lars Björck, and Arne Egesten. "Peptidoglycan from Staphylococcus aureus Induces Tissue Factor Expression and Procoagulant Activity in Human Monocytes." Infection and Immunity 70, no. 6 (June 2002): 3033–39. http://dx.doi.org/10.1128/iai.70.6.3033-3039.2002.
Sutton, Joshua A. F., Oliver T. Carnell, Lucia Lafage, Joe Gray, Jacob Biboy, Josie F. Gibson, Eric J. G. Pollitt, et al. "Staphylococcus aureus cell wall structure and dynamics during host-pathogen interaction." PLOS Pathogens 17, no. 3 (March 31, 2021): e1009468. http://dx.doi.org/10.1371/journal.ppat.1009468.
Wang, Yong, Zhiguang Liang, Yuanyuan Zheng, Alan Siu-Lun Leung, Siu-Cheong Yan, Pui-Kin So, Yun-Chung Leung, Wing-Leung Wong, and Kwok-Yin Wong. "Rational structural modification of the isatin scaffold to develop new and potent antimicrobial agents targeting bacterial peptidoglycan glycosyltransferase." RSC Advances 11, no. 29 (2021): 18122–30. http://dx.doi.org/10.1039/d1ra02119b.
Biswas, Lalitha, Raja Biswas, Martin Schlag, Ralph Bertram, and Friedrich Götz. "Small-Colony Variant Selection as a Survival Strategy for Staphylococcus aureus in the Presence of Pseudomonas aeruginosa." Applied and Environmental Microbiology 75, no. 21 (August 28, 2009): 6910–12. http://dx.doi.org/10.1128/aem.01211-09.
Francius, Grégory, Oscar Domenech, Marie Paule Mingeot-Leclercq, and Yves F. Dufrêne. "Direct Observation of Staphylococcus aureus Cell Wall Digestion by Lysostaphin." Journal of Bacteriology 190, no. 24 (October 3, 2008): 7904–9. http://dx.doi.org/10.1128/jb.01116-08.
Leanse, Leon G., Xiaojing Zeng, and Tianhong Dai. "Potentiated antimicrobial blue light killing of methicillin resistant Staphylococcus aureus by pyocyanin." Journal of Photochemistry and Photobiology B: Biology 215 (February 2021): 112109. http://dx.doi.org/10.1016/j.jphotobiol.2020.112109.
Mattsson, Eva, Terese Persson, Pia Andersson, Jan Rollof, and Arne Egesten. "Peptidoglycan Induces Mobilization of the Surface Marker for Activation Marker CD66b in Human Neutrophils but Not in Eosinophils." Clinical Diagnostic Laboratory Immunology 10, no. 3 (May 2003): 485–88. http://dx.doi.org/10.1128/cdli.10.3.485-488.2003.
Imegwu, Obi, Tsueng H. Chang, Jacob J. Steinberg, and Stanley M. Levenson. "Staphylococcus aureus peptidoglycan ameliorates cyclophosphamide-induced impairment of wound healing." Wound Repair and Regeneration 5, no. 4 (October 1997): 364–72. http://dx.doi.org/10.1046/j.1460-9568.1997.50411.x.
Singh, Vineet K., Mary R. Carlos, and Kuldeep Singh. "Physiological significance of the peptidoglycan hydrolase, LytM, in Staphylococcus aureus." FEMS Microbiology Letters 311, no. 2 (August 25, 2010): 167–75. http://dx.doi.org/10.1111/j.1574-6968.2010.02087.x.
Qiu, Jian-Gian, Stephen Factor, Tsueng H. Chang, David Knighton, Howard Nadel, and Stanley M. Levenson. "Wound Healing: Captopril, an Angiogenesis Inhibitor, and Staphylococcus aureus Peptidoglycan." Journal of Surgical Research 92, no. 2 (August 2000): 177–85. http://dx.doi.org/10.1006/jsre.2000.5839.
Gonzalez-Delgado, Luz S., Hannah Walters-Morgan, Bartłomiej Salamaga, Angus J. Robertson, Andrea M. Hounslow, Elżbieta Jagielska, Izabela Sabała, Mike P. Williamson, Andrew L. Lovering, and Stéphane Mesnage. "Two-site recognition of Staphylococcus aureus peptidoglycan by lysostaphin SH3b." Nature Chemical Biology 16, no. 1 (November 4, 2019): 24–30. http://dx.doi.org/10.1038/s41589-019-0393-4.
WYKE, Anne W., J. Barrie WARD, and Michael V. HAYES. "Synthesis of Peptidoglycan in vivo in Methicillin-Resistant Staphylococcus aureus." European Journal of Biochemistry 127, no. 3 (March 3, 2005): 553–58. http://dx.doi.org/10.1111/j.1432-1033.1982.tb06907.x.
Towhid, Syeda T., Mulugeta Nega, Eva-Maria Schmidt, Evi Schmid, Till Albrecht, Patrick Münzer, Oliver Borst, Friedrich Götz, and Florian Lang. "Stimulation of platelet apoptosis by peptidoglycan from Staphylococcus aureus 113." Apoptosis 17, no. 9 (July 3, 2012): 998–1008. http://dx.doi.org/10.1007/s10495-012-0718-1.
Dörries, Kirsten, Rabea Schlueter, and Michael Lalk. "Impact of Antibiotics with Various Target Sites on the Metabolome of Staphylococcus aureus." Antimicrobial Agents and Chemotherapy 58, no. 12 (September 15, 2014): 7151–63. http://dx.doi.org/10.1128/aac.03104-14.
Kraus, Dirk, Hubert Kalbacher, Julia Buschmann, Brigitte Berger-Bächi, Friedrich Götz, and Andreas Peschel. "Muropeptide Modification-Amidation of Peptidoglycan d-Glutamate Does Not Affect the Proinflammatory Activity of Staphylococcus aureus." Infection and Immunity 75, no. 4 (January 29, 2007): 2084–87. http://dx.doi.org/10.1128/iai.01576-06.
Chan, Yvonne G. Y., Matthew B. Frankel, Dominique Missiakas, and Olaf Schneewind. "SagB Glucosaminidase Is a Determinant of Staphylococcus aureus Glycan Chain Length, Antibiotic Susceptibility, and Protein Secretion." Journal of Bacteriology 198, no. 7 (January 25, 2016): 1123–36. http://dx.doi.org/10.1128/jb.00983-15.
Bera, Agnieszka, Raja Biswas, Silvia Herbert, Emir Kulauzovic, Christopher Weidenmaier, Andreas Peschel, and Friedrich Götz. "Influence of Wall Teichoic Acid on Lysozyme Resistance in Staphylococcus aureus." Journal of Bacteriology 189, no. 1 (November 3, 2006): 280–83. http://dx.doi.org/10.1128/jb.01221-06.
Nasibian, L. S., H. V. Sotkis, O. M. Tzugorko, I. B. Philippov, and Ya M. Shuba. "PEPTIDOGLYCAN OF STAPHYLOCOCCUS AUREUS ALTERS THE MYOMETRIAL CONTRACTILITY OF NON-PREGNANT RATS TROUGH INCREASING INTRACELLULAR CALCIUM LEVELS." Fiziolohichnyĭ zhurnal 66, no. 6 (November 22, 2020): 56–65. http://dx.doi.org/10.15407/fz66.06.056.
Mattsson, Eva, Thomas Hartung, Siegfried Morath, and Arne Egesten. "Highly Purified Lipoteichoic Acid from Staphylococcus aureus Induces Procoagulant Activity and Tissue Factor Expression in Human Monocytes but Is a Weak Inducer in Whole Blood: Comparison with Peptidoglycan." Infection and Immunity 72, no. 7 (July 2004): 4322–26. http://dx.doi.org/10.1128/iai.72.7.4322-4326.2004.
Pereira, S. F. F., A. O. Henriques, M. G. Pinho, H. de Lencastre, and A. Tomasz. "Role of PBP1 in Cell Division of Staphylococcus aureus." Journal of Bacteriology 189, no. 9 (February 16, 2007): 3525–31. http://dx.doi.org/10.1128/jb.00044-07.
Quiblier, Chantal, Agnieszka Luczak-Kadlubowska, Esther Holdener, Daniela Alborn, Tanja Schneider, Imke Wiedemann, Mariana Pinho, et al. "The Staphylococcus aureus Membrane Protein SA2056 Interacts with Peptidoglycan Synthesis Enzymes." Antibiotics 2, no. 1 (January 22, 2013): 11–27. http://dx.doi.org/10.3390/antibiotics2010011.
Wang, X., N. Mani, P. A. Pattee, B. J. Wilkinson, and R. K. Jayaswal. "Analysis of a peptidoglycan hydrolase gene from Staphylococcus aureus NCTC 8325." Journal of Bacteriology 174, no. 19 (1992): 6303–6. http://dx.doi.org/10.1128/jb.174.19.6303-6306.1992.
Snowden, Michael A., and Harold R. Perkins. "Peptidoglycan cross-linking in Staphylococcus aureus. An apparent random polymerisation process." European Journal of Biochemistry 191, no. 2 (July 1990): 373–77. http://dx.doi.org/10.1111/j.1432-1033.1990.tb19132.x.
Jacob, E., L. C. Durham, M. C. Falk, T. J. Williams, and L. J. Wheat. "Antibody response to teichoic acid and peptidoglycan in Staphylococcus aureus osteomyelitis." Journal of Clinical Microbiology 25, no. 1 (1987): 122–27. http://dx.doi.org/10.1128/jcm.25.1.122-127.1987.
Pintar, Sara, Jure Borišek, Aleksandra Usenik, Andrej Perdih, and Dušan Turk. "Interdomain conformational flexibility of the peptidoglycan N-acetylglucosaminidases of Staphylococcus aureus." Acta Crystallographica Section A Foundations and Advances 75, a2 (August 18, 2019): e125-e125. http://dx.doi.org/10.1107/s2053273319094312.
Reikerås, Olav, Jacob E. Wang, Simon J. Foster, and Stein E. Utvåg. "Staphylococcus aureus peptidoglycan impairs fracture healing: An experimental study in rats." Journal of Orthopaedic Research 25, no. 2 (February 2007): 262–66. http://dx.doi.org/10.1002/jor.20274.
Voggu, Lalitha, Steffen Schlag, Raja Biswas, Ralf Rosenstein, Christian Rausch, and Friedrich Götz. "Microevolution of Cytochrome bd Oxidase in Staphylococci and Its Implication in Resistance to Respiratory Toxins Released by Pseudomonas." Journal of Bacteriology 188, no. 23 (December 1, 2006): 8079–86. http://dx.doi.org/10.1128/jb.00858-06.
Gründling, Angelika, and Olaf Schneewind. "Cross-Linked Peptidoglycan Mediates Lysostaphin Binding to the Cell Wall Envelope of Staphylococcus aureus." Journal of Bacteriology 188, no. 7 (April 1, 2006): 2463–72. http://dx.doi.org/10.1128/jb.188.7.2463-2472.2006.
Leemans, Jaklien C., Mirjam Heikens, Kok P. M. van Kessel, Sandrine Florquin, and Tom van der Poll. "Lipoteichoic Acid and Peptidoglycan from Staphylococcus aureus Synergistically Induce Neutrophil Influx into the Lungs of Mice." Clinical Diagnostic Laboratory Immunology 10, no. 5 (September 2003): 950–53. http://dx.doi.org/10.1128/cdli.10.5.950-953.2003.
Balibar, Carl J., Xiaoyu Shen, and Jianshi Tao. "The Mevalonate Pathway of Staphylococcus aureus." Journal of Bacteriology 191, no. 3 (November 21, 2008): 851–61. http://dx.doi.org/10.1128/jb.01357-08.
Bon, Jon, Nagraj Mani, and R. K. Jayaswal. "Molecular analysis of lytic genes of bacteriophage 80α ofStaphylococcus aureus." Canadian Journal of Microbiology 43, no. 7 (July 1, 1997): 612–16. http://dx.doi.org/10.1139/m97-087.
Stapleton, Melanie R., Malcolm J. Horsburgh, Emma J. Hayhurst, Lynda Wright, Ing-Marie Jonsson, Andrej Tarkowski, John F. Kokai-Kun, James J. Mond, and Simon J. Foster. "Characterization of IsaA and SceD, Two Putative Lytic Transglycosylases of Staphylococcus aureus." Journal of Bacteriology 189, no. 20 (August 3, 2007): 7316–25. http://dx.doi.org/10.1128/jb.00734-07.
Wu, Julie A., Caroline Kusuma, James J. Mond, and John F. Kokai-Kun. "Lysostaphin Disrupts Staphylococcus aureus and Staphylococcus epidermidis Biofilms on Artificial Surfaces." Antimicrobial Agents and Chemotherapy 47, no. 11 (November 2003): 3407–14. http://dx.doi.org/10.1128/aac.47.11.3407-3414.2003.
de Jonge, B. L., Y. S. Chang, N. Xu, and D. Gage. "Effect of exogenous glycine on peptidoglycan composition and resistance in a methicillin-resistant Staphylococcus aureus strain." Antimicrobial Agents and Chemotherapy 40, no. 6 (June 1996): 1498–503. http://dx.doi.org/10.1128/aac.40.6.1498.
Jones, Carys S., Alexander C. Anderson, and Anthony J. Clarke. "Mechanism of Staphylococcus aureus peptidoglycan O-acetyltransferase A as an O-acyltransferase." Proceedings of the National Academy of Sciences 118, no. 36 (September 3, 2021): e2103602118. http://dx.doi.org/10.1073/pnas.2103602118.
Dziarski, Roman, and Dipika Gupta. "Staphylococcus aureus Peptidoglycan Is a Toll-Like Receptor 2 Activator: a Reevaluation." Infection and Immunity 73, no. 8 (August 2005): 5212–16. http://dx.doi.org/10.1128/iai.73.8.5212-5216.2005.
Johannsen, L., L. A. Toth, R. S. Rosenthal, M. R. Opp, F. Obal, A. B. Cady, and J. M. Krueger. "Somnogenic, pyrogenic, and hematologic effects of bacterial peptidoglycan." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 258, no. 1 (January 1, 1990): R182—R186. http://dx.doi.org/10.1152/ajpregu.1990.258.1.r182.
Tong, Steven Y. C., Frieder Schaumburg, Matthew J. Ellington, Jukka Corander, Bruno Pichon, Fabian Leendertz, Stephen D. Bentley, et al. "Novel staphylococcal species that form part of a Staphylococcus aureus-related complex: the non-pigmented Staphylococcus argenteus sp. nov. and the non-human primate-associated Staphylococcus schweitzeri sp. nov." International Journal of Systematic and Evolutionary Microbiology 65, Pt_1 (January 1, 2015): 15–22. http://dx.doi.org/10.1099/ijs.0.062752-0.
Boyle-Vavra, Susan, Harald Labischinski, Christine C. Ebert, Kerstin Ehlert, and Robert S. Daum. "A Spectrum of Changes Occurs in Peptidoglycan Composition of Glycopeptide-Intermediate Clinical Staphylococcus aureus Isolates." Antimicrobial Agents and Chemotherapy 45, no. 1 (January 1, 2001): 280–87. http://dx.doi.org/10.1128/aac.45.1.280-287.2001.
Zhao, Wei-Hua, Zhi-Qing Hu, Sachie Okubo, Yukihiko Hara, and Tadakatsu Shimamura. "Mechanism of Synergy between Epigallocatechin Gallate and β-Lactams against Methicillin-Resistant Staphylococcus aureus." Antimicrobial Agents and Chemotherapy 45, no. 6 (June 1, 2001): 1737–42. http://dx.doi.org/10.1128/aac.45.6.1737-1742.2001.
Périchon, Bruno, and Patrice Courvalin. "VanA-Type Vancomycin-Resistant Staphylococcus aureus." Antimicrobial Agents and Chemotherapy 53, no. 11 (June 8, 2009): 4580–87. http://dx.doi.org/10.1128/aac.00346-09.
Feng, Bai-Sui, Shao-Heng He, Peng-Yuan Zheng, Linda Wu, and Ping-Chang Yang. "Mast Cells Play a Crucial Role in Staphylococcus aureus Peptidoglycan-Induced Diarrhea." American Journal of Pathology 171, no. 2 (August 2007): 537–47. http://dx.doi.org/10.2353/ajpath.2007.061274.
Henze, U., T. Sidow, J. Wecke, H. Labischinski, and B. Berger-Bächi. "Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus." Journal of Bacteriology 175, no. 6 (1993): 1612–20. http://dx.doi.org/10.1128/jb.175.6.1612-1620.1993.
Wang, Jacob E., Maria K. Dahle, Arne Yndestad, Inge Bauer, Michelle C. McDonald, Pål Aukrust, Simon J. Foster, Michael Bauer, Ansgar O. Aasen, and Christoph Thiemermann. "Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat*." Critical Care Medicine 32, no. 2 (February 2004): 546–52. http://dx.doi.org/10.1097/01.ccm.0000109775.22138.8f.
Reichmann, Nathalie T., Andreia C. Tavares, Bruno M. Saraiva, Ambre Jousselin, Patricia Reed, Ana R. Pereira, João M. Monteiro, et al. "SEDS–bPBP pairs direct lateral and septal peptidoglycan synthesis in Staphylococcus aureus." Nature Microbiology 4, no. 8 (May 13, 2019): 1368–77. http://dx.doi.org/10.1038/s41564-019-0437-2.